OCT1 Polyspecificity—Friend or Foe?

Overview of attention for article published in Frontiers in Pharmacology, June 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,151 followers.

RT @FrontPharmacol: New Research: OCT1 Polyspecificity—Friend or Foe? https://t.co/5LAsA7RWW6 #pharmacology

New Research: OCT1 Polyspecificity—Friend or Foe? https://t.co/5LAsA7RWW6 #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.